LBP-EC01 CRISPR-Enhanced Bacteriophage UTI Therapy Clinical Trials, Indication, Side Effects
Locus Biosciences LBP-EC01 CRISPR-enhanced bacteriophage (crPhage®) therapy in development for treating urinary tract infections (UTI) and other infections caused by... Read more...